Dynamics of cell-free DNA levels in the in vivo LPS-induced inflammation model

封面

如何引用文章

全文:

详细

An increased concentration of extracellular cell free DNA (cfDNA) is a distinctive characteristic of pathologies that mainly occur in acute inflammation (myocardial infarction, sepsis, stroke, trauma). The increase of cfDNA in chronic inflammatory processes, oncological, autoimmune diseases is less significant and is mainly due to aberrant cell death processes. One of such diseases is systemic lupus erythematosus (SLE). It has recently been shown that, in addition to increased cfDNA concentration, the degree of inflammation can reflect the N/L index (neutrophil to lymphocyte ratio), being a simple and informative marker of disease activity in patients with SLE. The aim of the study was to study the dynamics of the level of cfDNA and the N/L index in the model of LPS-induced inflammatory response as observed in intact mice, and their relation to the phenotypic heterogeneity of model SLE. We used female hybrid mice (C57Bl/6xDBA/2) F1 and female DBA/2 mice at the age of 6-8 weeks. LPS of E. coli strain 111: B4 (Sigma) was injected intraperitoneally once at doses of 10 ng, 1 µg and 100 µg per mouse in PBS. The control group was injected with the appropriate volume of buffer. The TNFα-binding domain of the variola virus CRMB protein was used as an inhibitor of TNFα, which was administered 30 min before the introduction of LPS. The dynamics of the response to LPS was assessed after 4, 8, 11, 24 hours by the N/L index and the level of cfDNA; at the zero point, the parameters were determined before the introduction of LPS. A day after a single injection of LPS at a dose of 1 µg/mouse, a SLE model was induced on the same hybrid mice (double intravenous administration with an interval of 6 days of spleen cells of the DBA/2 line, 60-70 × 106 cells each). Three months later, with proteinuria of 3 mg/ mL or more, mice were assigned to the SLEnephritis+ group, with a protein of less than 3 mg/mL, to the SLEnephritis- group. Statistical processing of the results was carried out by nonparametric statistics using the Mann–Whitney test. Differences were considered statistically significant at p < 0.05. It was found that the change in the N/L index, as well as the change in the level of cfDNA, depends on the dose of LPS administered. It was shown that the level of cfDNA reaches its maximum after 8 and 11 hours after the introduction of LPS is reliably reduced when using the inhibitor TNFα. A retrospective analysis indicates that there is a definite relationship between the response of intact mice to LPS before induction of cGVHD, and their subsequent division into variants of SLEnephritis + and SLEnephritis - in the course of disease development.

作者简介

E. Demchenko

Research Institute of Fundamental and Clinical Immunology

Email: edav.gavr@mail.ru

PhD (Chemistry), Research Associate, Laboratory of Experimental Immunotherapy

俄罗斯联邦, Novosibirsk

E. Gavrilova

Research Institute of Fundamental and Clinical Immunology

编辑信件的主要联系方式.
Email: edav.gavr@mail.ru

PhD (Biology), Head, Laboratory of Experimental Immunotherapy

俄罗斯联邦, Novosibirsk

E. Goiman

Research Institute of Fundamental and Clinical Immunology

Email: edav.gavr@mail.ru

PhD (Medicine), Research Associate, Laboratory of Experimental Immunotherapy

俄罗斯联邦, Novosibirsk

N. Volskiy

Research Institute of Fundamental and Clinical Immunology

Email: edav.gavr@mail.ru

PhD (Medicine), Leading Research Associate, Laboratory of Experimental Immunotherapy

俄罗斯联邦, Novosibirsk

V. Kozlov

Research Institute of Fundamental and Clinical Immunology

Email: edav.gavr@mail.ru

PhD, MD (Medicine), Professor, Full Member, Russian Academy of Medical Sciences, Research Director

俄罗斯联邦, Novosibirsk

参考

  1. Колесникова О.П., Кудаева О.Т., Вольский Н.Н., Гойман Е.В., Гаврилова Е.Д., Перминова О.М., Демченко Е.Н., Козлов В.А. Экспериментальная модель аутоиммунного процесса: роль эпигенетической изменчивости в популяции мышей-гибридов // Вестник РАМН, 2015. Т. 70, № 2. С. 152-158. [Kolesnikova O.P., Kudaeva O.T., Volsky N.N., Goiman E.V., Gavrilova E.D., Perminova O.M., Demchenko E.N., Kozlov V.A. Experimental model of the autoimmune process: the role of epigenetic variability in the population of hybrid mice. Vestnik RAMN = Bulletin of the Russian Academy of Medical Sciences, 2015, Vol. 70, no. 2. pp. 152-158. (In Russ.)]
  2. Almoallim H., Al-Ghamdi Y., Almaghrabi H., Alyasi O. Anti-tumor necrosis factor-alpha induced systemic lupus erythematosu. Open Rheumatol. J., 2012, Vol. 6, pp. 315-319.
  3. Gileva I.P., Nepomnyashchikh T.S., Ryazankin I.A., Shchelkunov S.N. Recombinant TNF-binding protein from variola virus as a novel potential TNF antagonist. Biochemistry (Mosc.), 2009, Vol. 74, no. 12, pp. 1356-1362.
  4. Kudaeva O.T., Kolesnikova O.P., Goiman E.V., Tkachev V.O., Volskiy N.N., Perminova O.M., Gavrilova E.D., Kozlov V.A. The experimental model of the autoimmune glomerulonephritis induced by the chronic graft versus host reaction // An update on glomerulopathies – Etiology and pathogenesis. Ed. by S.S.Prabhakar. Rijeka: In Tech, 2011, pp. 49-86.
  5. LiL., XiaY., Chen C., Cheng P., Peng C. Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int. J. Clin. Exp. Med ., 2015, Vol. 8, no. 7. pp. 11026-11031.
  6. Miralda I., Uriarte S.M., McLeish K.R. Multiple phenotypic changes define neutrophil priming. Front. Cell Infect. Microbiol., 2017, Vol. 7, 217. doi: 10.3389/fcimb.2017.00217.
  7. Sabroe I., Dower S.K., Whyte M.K. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin. Infect Dis., 2005, Vol. 41, Suppl. 7, pp. S421-S426.
  8. Swarup V., Rajeswari M.R. Circulating (cell-free) nucleic acids – a promising, non-invasive tool for early detection of several human diseases. FEBS Lett., 2007, Vol. 581, no. 5, pp. 795-799.
  9. Tamkovich S.N., Litviakov N.V., Bryzgunova O.E., Dobrodeev A.Y., Rykova E.Y., Tuzikov S.A., Zav’ialov A.A., Vlassov V.V., Cherdyntseva N.V., Laktionov P.P. Cell-surface-bound circulating DNA as a prognostic factor in lung cancer. Ann. N. Y. Acad. Sci., 2008, Vol. 1137, pp. 214-217.
  10. Tschetter J.R., Mozes E., Shearer G.M. Progression from Acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J. Immunol., 2000, Vol. 165, pp. 5987-5994.
  11. Yang Q.S., He L.P., Zhou X.L., Zhao Y., Shen J., Xu P., Ni S.Z. Kaempferol pretreatment modulates systemic inflammation and oxidative stress following hemorrhagic shock in mice. Chin. Med., 2015, no. 10, 6. doi: 10.1186/s13020-015-0035-z.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Demchenko E.N., Gavrilova E.D., Goiman E.V., Volskiy N.N., Kozlov V.A., 2022

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
##common.cookie##